Key facts
- This page summarizes John E. Bishop's Form 3 filing for Lyra Therapeutics, Inc. (LYRA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2023, 15:05.
John E. Bishop - 27 Feb 2023 Form 3 Insider Report for Lyra Therapeutics, Inc. (LYRA)
- Reporting relationship
- Chief Technology Officer
- Issuer ticker
- LYRA
- Reported as of
- 27 Feb 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 28 Feb 2023, 15:05:20 UTC
- Prior SEC filing
- 14 Oct 2022
- Next SEC filing
- 01 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason Cavalier, Attorney-in-Fact for John E. Bishop
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Bishop filed Form 3 for Lyra Therapeutics, Inc. (LYRA) on 28 Feb 2023.
Change
- Previous filing in this sequence was filed on 14 Oct 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Exhibit 24 - Power of Attorney.